Share on StockTwits

Sinovac Biotech (NYSE:SVA) posted its quarterly earnings results on Thursday. The company reported ($0.04) earnings per share (EPS) for the quarter, Stock Ratings Network.com reports. The company had revenue of $12.10 million for the quarter, compared to the consensus estimate of $17.20 million.

Sinovac Biotech (NYSE:SVA) traded down 0.89% during mid-day trading on Thursday, hitting $5.57. 97,775 shares of the company’s stock traded hands. Sinovac Biotech has a 52-week low of $4.51 and a 52-week high of $8.14. The stock has a 50-day moving average of $5.61 and a 200-day moving average of $6.1. The company has a market cap of $309.6 million and a P/E ratio of 33.25.

On a related note, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Sinovac Biotech in a research note on Tuesday, May 27th. They now have a $9.00 price target on the stock.

Sinovac Biotech Ltd. (NYSE:SVA) is a holding company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.